New gene therapy targets brain disorders

November 9, 2017 by Wendy Van Zuijlen, University of New South Wales
New gene therapy developed with UNSW researchers targets brain disorders
Credit: Shutterstock

UNSW researchers have tailored gene therapy for a rare genetic disorder called Canavan disease, and say it could eventually be adapted to treat other inherited disorders affecting the brain.

A group of researchers led by UNSW Sydney has developed a new gene therapy that may reverse the devastating symptoms of disorders such as Canavan .

Canavan disease is a rare, fatal in which an enzyme called aspartoacylase is not active. This enzyme breaks down the amino acid NAA in the body.

In individuals with Canavan disease, NAA is not broken down and progressively damages the brain's white matter and its ability to support cellular communication in the nervous system. Over time, this damage causes symptoms such as lack of motor skills, weak muscle tone, developmental delay and seizures.

"In our previous study in rats with Canavan disease, we used gene therapy to restore aspartoacylase in called neurons, but the effects were very modest," said study leader Professor Matthias Klugmann from the Translational Neuroscience Facility in the School of Medical Sciences.

"This is when we reasoned that there must be a better cell type in the brain that we can target.

"Employing genetic engineering in mice, we found that other brain cells called oligodendrocytes are the only brain cells that normally make aspartoacylase, and that aspartoacylase in this cell type prevents brain damage by excess NAA. Therefore, we tailored the gene therapy around these cells.

"The basic technology that we used to deliver a normal copy of the aspartoacylase gene to neurons has been around for two decades. But we have now developed it to limit the activity of the therapeutic aspartoacylase gene to oligodendrocyte cells."

Lead author Dr Georg von Jonquieres, from the Translational Neuroscience Facility, said that in the study, the research team treated mice with symptoms of Canavan disease with the new gene therapy. When they took a magnetic resonance scan of the brains and tested their motor and behavioural skills, they found that the therapy reversed the disease symptoms.

Professor Klugmann said the researchers chose Canavan disease to test the but in the long-term, this technology could also be adapted to treat different leukodystrophies, which are inherited disorders whereby the brain's white matter is similarly affected.

The study was published in the journal Acta Neuropathologica.

Explore further: Team makes breakthrough in understanding Canavan disease

More information: Georg von Jonquieres et al. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy, Acta Neuropathologica (2017). DOI: 10.1007/s00401-017-1784-9

Related Stories

Team makes breakthrough in understanding Canavan disease

April 27, 2015
UC Davis investigators have settled a long-standing controversy surrounding the molecular basis of an inherited disorder that historically affected Ashkenazi Jews from Eastern Europe but now also arises in other populations ...

Gene immunotherapy protects against multiple sclerosis in mice

September 21, 2017
A potent and long-lasting gene immunotherapy approach prevents and reverses symptoms of multiple sclerosis in mice, according to a study published September 21st in the journal Molecular Therapy. Multiple sclerosis is an ...

Gene therapy cocktail shows promise in long-term clinical trial for rare fatal brain disorder

December 19, 2012
Results of a clinical trial that began in 2001 show that a gene therapy cocktail conveyed into the brain by a molecular special delivery vehicle may help extend the lives of children with Canavan disease, a rare and fatal ...

Gene therapy shows promise for treating Niemann-Pick disease type C1

October 26, 2016
For the first time, National Institutes of Health (NIH) researchers have demonstrated in mice that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick disease, type C1 (NPC1). ...

Conversion of brain cells offers hope for Parkinson's patients

April 11, 2017
Researchers at Karolinska Institutet have made significant progress in the search for new treatments for Parkinson's disease. By manipulating the gene expression of non-neuronal cells in the brain, they were able to produce ...

CD38 gene is identified to be important in postnatal development of the cerebral cortex

April 7, 2017
The brain consists of neurons and glial cells. The developmental abnormality of glial cells causes various diseases and aberrant cerebral cortex development. CD38 gene knockout is shown to cause aberrant development of glial ...

Recommended for you

Researchers unravel why people with HIV suffer from more neurologic diseases

August 20, 2018
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), which the HIV virus can cause, continue to be one of the world's greatest health problems.

Fluidically linked blood-brain barrier and Organ Chips offer new method for studying effects of drugs on the brain

August 20, 2018
The human brain, with its 100 billion neurons that control every thought, word, and action, is the most complex and delicate organ in the body. Because it needs extra protection from toxins and other harmful substances, the ...

Female mice are immune to cognitive damage from space radiation

August 20, 2018
Humankind still dreams of breaking from the bounds of Earth's atmosphere and venturing to the moon, Mars and beyond. But once astronauts blast past the International Space Station, they become exposed to one of the many dangers ...

Children with brain tumors who undergo radiation less likely to recall recent events

August 20, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events they experienced after radiation than to remember pre-treatment happenings, according to a Baylor ...

Rogue proteins may underlie some ALS and frontotemporal dementia cases, says study

August 20, 2018
ALS—amyotrophic lateral sclerosis—is a neurodegenerative disease that attacks motor neurons in the brain and spinal cord, slowly robbing its victims of their ability to walk, talk, breathe and swallow. In a cruel twist, ...

Bilingual children who speak native language at home have higher intelligence

August 20, 2018
Children who regularly use their native language at home while growing up in a different country have higher IQs, a new study has shown.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.